Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX.TA) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-17.04

-13.73

-10.43

-7.12

Details

Expected EPS

-9.152744016000002

Actual EPS

-7.118880000000001

Surprise EPS

2.03

Surprise Percent

+22.22%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -7.118880000000001 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.